Disruptech Ventures

Disruptech Ventures is a Cairo-based primarily fintech-focused fund whose investments in payment infrastructure and AI-enabled software directly enable the operational scaling of digital health and telemedicine platforms. The fund writes Seed and Series A checks in the $250k to $1M range and treats healthcare as adjacent to its core fintech thesis: any healthcare company that depends on Egyptian or African payment rails, embedded insurance, BNPL for clinical services, or financial infrastructure for telemedicine sits within Disruptech’s relevant orbit. Founders building pure clinical AI without a payments angle, biotech, or care delivery brick-and-mortar should look at sector-specialist funds such as Algebra or Foundation. The right founder is an Egyptian or North African technical or commercial operator with a credible fintech-and-health hybrid thesis, often at the intersection of telemedicine, embedded insurance, pharmacy fulfillment, or clinic financing. Disruptech is most useful when the fintech angle is genuinely load-bearing, not a contortion to fit the fund’s mandate. Geographic advantage is real fintech depth in Egypt and North Africa, connectivity into payment processors and banks, and relationships with Egyptian regulators that shape financial services and adjacent healthcare. Best entry is a warm intro from a portfolio founder or a regional co-investor; cold inbound is read but standards are sharper than fund size suggests. Lead the pitch with the fintech-health integration, real revenue or strong demand-side signals, and a credible cross-border expansion plan across MENA. Be explicit about Egyptian Central Bank rules where relevant, data residency, and how the product handles PHI flows alongside financial data. Caveats: fund-thesis fit really matters here, and founders forcing a healthcare-only narrative will run into a wall during partner conversations. Ask Disruptech directly about reserves, prorata behavior, and which Series A and B leads have followed the fund into health-adjacent portfolio companies. Egyptian pound volatility and capital-controls history shape operating budgets, and savvy founders structure rounds accordingly. Confirm fund vintage and remaining deployment. Reference checks with current portfolio CEOs on operating support, regulator navigation, and follow-on introductions are worth the time. Used appropriately, Disruptech is a credible Egyptian fintech-with-healthcare-adjacency partner for founders whose health business genuinely runs on payments rails; for pure clinical or care delivery founders, it is a poor fit.